Ultralife Corporation
ULBI
$9.14
-$0.01-0.11%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 42.98M | 41.93M | 44.55M | 39.49M | 42.69M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 42.98M | 41.93M | 44.55M | 39.49M | 42.69M |
| Cost of Revenue | 31.42M | 30.46M | 33.15M | 29.71M | 32.10M |
| Gross Profit | 11.56M | 11.47M | 11.40M | 9.77M | 10.59M |
| SG&A Expenses | 5.65M | 5.65M | 5.90M | 5.77M | 5.15M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 39.07M | 37.86M | 40.90M | 37.35M | 39.03M |
| Operating Income | 3.92M | 4.06M | 3.65M | 2.14M | 3.67M |
| Income Before Tax | 3.85M | 3.61M | 3.11M | 1.75M | 4.72M |
| Income Tax Expenses | 853.00K | 703.00K | 263.00K | 446.00K | 1.38M |
| Earnings from Continuing Operations | 2.99M | 2.90M | 2.85M | 1.30M | 3.35M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -24.00K | -13.00K | 23.00K | 27.00K | -8.00K |
| Net Income | 2.97M | 2.89M | 2.87M | 1.33M | 3.34M |
| EBIT | 3.92M | 4.06M | 3.65M | 2.14M | 3.67M |
| EBITDA | 4.93M | 5.03M | 4.62M | 3.12M | 4.65M |
| EPS Basic | 0.18 | 0.18 | 0.18 | 0.08 | 0.21 |
| Normalized Basic EPS | 0.14 | 0.14 | 0.06 | 0.07 | 0.18 |
| EPS Diluted | 0.18 | 0.18 | 0.17 | 0.08 | 0.21 |
| Normalized Diluted EPS | 0.14 | 0.14 | 0.06 | 0.07 | 0.18 |
| Average Basic Shares Outstanding | 16.57M | 16.40M | 16.34M | 16.24M | 16.14M |
| Average Diluted Shares Outstanding | 16.83M | 16.52M | 16.48M | 16.30M | 16.14M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
